Topics

Dyadic International board member highlights upcoming milestones

06:15 EDT 2 Jul 2019 | Proactive Investors

Dyadic International Inc (NASDAQ:DYAI) board member Dr Arin Bose, a 34-year Pfizer (NYSE:PFE) veteran, talks to Proactive Investors about what went into choosing Dyadic's research partners VTT Technical Research Centre of Finland Ltd and Spain-based biotech BDI Holdings.

Dr Bose also highlighted upcoming milestones for the biotechnology platform company. To see more of Dr Bose's background, please click here

Original Article: Dyadic International board member highlights upcoming milestones

NEXT ARTICLE

More From BioPortfolio on "Dyadic International board member highlights upcoming milestones"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...